P3 Health Partners (NASDAQ:PIII - Get Free Report) will be announcing its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. P3 Health Partners has set its FY 2024 guidance at EPS.Investors that wish to register for the company's conference call can do so using this link.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its earnings results on Thursday, March 28th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.03). The company had revenue of $346.86 million for the quarter, compared to analysts' expectations of $309.80 million. P3 Health Partners had a negative net margin of 4.56% and a negative return on equity of 120.85%. On average, analysts expect P3 Health Partners to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
P3 Health Partners Stock Performance
PIII traded up $0.04 during mid-day trading on Friday, reaching $0.64. 359,671 shares of the company traded hands, compared to its average volume of 376,171. The stock has a market capitalization of $202.08 million, a P/E ratio of -0.87 and a beta of 1.26. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.76. The company's fifty day moving average price is $0.82 and its 200-day moving average price is $1.10. P3 Health Partners has a 52-week low of $0.44 and a 52-week high of $5.56.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on PIII shares. Lake Street Capital decreased their target price on shares of P3 Health Partners from $9.00 to $4.50 and set a "buy" rating for the company in a research note on Thursday, March 14th. BTIG Research lowered P3 Health Partners from a "buy" rating to a "neutral" rating in a research note on Monday, April 1st. Finally, William Blair restated an "outperform" rating on shares of P3 Health Partners in a research note on Monday, April 1st.
View Our Latest Research Report on PIII
About P3 Health Partners
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
See Also
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
